Risk of cancer in children exposed to didanosine in utero.
Fiche publication
Date publication
mai 2016
Journal
AIDS (London, England)
Auteurs
Membres identifiés du Cancéropôle Est :
Dr JANNIER Sarah
Tous les auteurs :
Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzi S, Stephan JL, Reliquet V, Jannier S, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S,
Lien Pubmed
Résumé
Evaluation of long-term tolerance to antiretroviral exposure during pregnancy is required. An increased risk of cancer has been suggested in children exposed in utero to didanosine.
Mots clés
Adolescent, Anti-HIV Agents, adverse effects, Child, Child, Preschool, Didanosine, adverse effects, Female, France, epidemiology, HIV Infections, drug therapy, Humans, Incidence, Infant, Infant, Newborn, Maternal-Fetal Exchange, Neoplasms, epidemiology, Pregnancy, Pregnancy Complications, Infectious, drug therapy, Prenatal Exposure Delayed Effects, epidemiology, Prospective Studies, Risk Assessment, Surveys and Questionnaires
Référence
AIDS. 2016 05 15;30(8):1245-56